TissGDB
Tissglogo

Home

Download

 Statistics

 Landscape

Help

Contact
Bioinformatics and Systems Medicine Laboratory Bioinformatics and Systems Medicine Laboratory

bullet point

TissGeneSummary

bullet point

TissGeneExp

bullet point

TissGene-miRNA

bullet point

TissGeneMut: TissGeneSNV, TissGeneCNV, and TissGeneFusions

bullet point

TissGeneNet

bullet point

TissGeneProg

bullet point

TissGeneClin: TissGeneDrug and TissGeneDisease

TissGeneSummary for CDX2
check button Gene summary
Basic gene informationGene symbolCDX2
Gene namecaudal type homeobox 2
SynonymsCDX-3|CDX2/AS|CDX3
CytomapUCSC genome browser: 13q12.3
Type of geneprotein-coding
RefGenesNM_001265.4,
Descriptioncaudal type homeo box transcription factor 2caudal type homeobox transcription factor 2caudal-type homeobox protein 2homeobox protein CDX-2
Modification date20141222
dbXrefs MIM : 600297
HGNC : HGNC
HPRD : 02622
ProteinUniProt:
go to UniProt's Cross Reference DB Table
ExpressionCleanEX: HS_CDX2
BioGPS: 1045
PathwayNCI Pathway Interaction Database: CDX2
KEGG: CDX2
REACTOME: CDX2
Pathway Commons: CDX2
ContextiHOP: CDX2
ligand binding site mutation search in PubMed: CDX2
UCL Cancer Institute: CDX2
Assigned class in TissGDB*C
Included tissue-specific gene expression resourcesTiGER,GTEx
Specific-tissues in normal samples (assigned by TissGDB using HPA, TiGER, and GTEx)Colon
Cancer types related to the specific-tissues in cancer samples (assigned by TissGDB using TCGA)COAD
Reference showing the relevant tissue of CDX2
Description by TissGene annotationsCancer gene
* Class A consists of genes with literature evidence and is part of the cTissGenes. Class B consists of only cTissGenes without additional evidence. The remaining genes belong to Class C.

check button Gene ontology having evidence of Inferred from Direct Assay (IDA) from Entrez
GO IDGO termPubMed ID
GO:0000122negative regulation of transcription from RNA polymerase II promoter15677472
GO:0000122negative regulation of transcription from RNA polymerase II promoter15677472


Top
TissGeneExp for CDX2

check button Gene expressions across 28 cancer types (X-axis: cancer type and Y-axis: log2(norm_counts+1))
(TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16)
gene exp


check button Gene isoform expressions across 28 cancer types (X-axis: cancer type and Y-axis: log2(norm_counts+1))
(TCGA pan-cancer tcga_rsem_isoform_tpm, version 2016-09-01)
gene isoform exp


check button Gene expressions across normal tissues of GTEx data
(GTEx GTEx_Analysis_v6_RNA-seq_RNA-SeQCv1.1.8_gene_rpkm.gct)
- Here, we shows the matched tissue types only among our 28 cancer types.
normal gene exp


check button Different expressions across 14 cancer types with more than 10 samples between matched tumors and normals (X-axis: cancer type and Y-axis: log2(norm_counts+1))
(TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16)
DEG exp

- Significantly differentially expressed cancer types and information. (|Fold change|>1 and FDR<0.05)
Cancer typeMean(exp) in tumorMean(exp) in matched normalLog2FCP-val.FDR
LUSC-0.508873389-2.4345675071.9256941181.09E-062.73E-06
LUAD-0.50469942-2.400649421.895956.74E-082.71E-07
ESCA4.33146547-1.4222163485.7536818180.001210.016611358
HNSC-0.695605354-2.0859588431.3903534880.002740.008101183
STAD5.988576552.5186234253.4699531258.88E-050.000690986


Top
TissGene-miRNA for CDX2

check button Significantly anti-correlated miRNAs of TissGene across 28 cancer types
(Gene-miRNA relations from TargetScanHuman Relsease 7.1, Conserved_Site_Context_Scores.txt.zip, 06.01.2016)
(TCGA IlluminaHiSeq_miRNASeq, log2(RPM+1) data, version 2016-11-21)
(TCGA IlluminaHiSeq_RNASeqV2, log2(normalized_count+1) data, version 2016-08-16)
(Spearman’s Rank Correlation (p-value<0.05 and coefficient<-0.25))
Cancer typemiRNA idmiRNA accessionP-val.Coeff.# samples
TGCThsa-miR-181b-5pMIMAT00002570.0011-0.26155
LUSChsa-miR-22-3pMIMAT00000770.002-0.27128


Top
TissGeneMut for CDX2
TissGeneSNV for CDX2

check button nsSNV counts per each loci.
Different colors of circles represent different cancer types. Circle size denotes number of samples.
(TCGA somatic mutation (SNPs and small INDELs) data, version 2016-04-25)
* Click on the image to enlarge it in a new window.
SNV lollipop
bullet point


check button Somatic nucleotide variants of TissGene across 28 cancer types
(X-axis: cancer type and Y-axis: % of mutated samples)
The numbers in parentheses are numbers of samples with mutation (nsSNVs).
(TCGA somatic mutation (SNPs and small INDELs) data, version 2016-04-25)
SNV distribution

- nsSNVs sorted by frequency.
AAchangeCancer type# samples
p.A50ELIHC1
p.S295PGBM1
p.R237CUCEC1
p.P61SLUSC1
p.A239VCOAD1
p.V311ILUAD1
p.H206YCESC1
p.R209HUCEC1
p.V311FLUAD1
p.Q255*LGG1
p.R214QUCEC1
p.A221TUCEC1
p.T185MUCEC1
p.A86VCESC1
p.L288VLUSC1
p.R237STHYM1
p.F205YSKCM1
p.P147TLUSC1
p.Q253ELUAD1
p.E241KSKCM1
p.R237CCOAD1
p.H206YHNSC1
p.A104VREAD1
p.P264SUCEC1
p.P274HSTAD1


Top
TissGeneCNV for CDX2

check button Copy number variations of TissGene across 28 cancer types (X-axis: cancer type and Y-axis: % of CNV samples)
(TCGA Gistic2_CopyNumber_Gistic2_all_data_by_genes, Gistic2 copy number data, version 2016-08-16)
CNV


Top
TissGeneFusions for CDX2

check button Fusion genes including TissGene
(ChimerDB 3.0, 2016-12-01 and TCGA fusion Portal 2015-12-01)
DatabaseSrcCancer typeSampleFusion geneORF5'-gene BP3'-gene BP


Top
TissGeneNet for CDX2

check button Co-expressed gene networks based on protein-protein interaction data (CePIN)
(TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16)
(PINA2 ppi data)
BRCA (tumor)BRCA (normal)
CDX2, CFTR, KDM5B, MAPK1, SMARCA2, CREBBP, CDK2, GSK3B, MAPK14, EP300, SMARCD1, PABPC1, CLDN2, PAX6, ACAT2, SI, MUC4, NOX1, MEX3B, GUCY2C, UGT1A6 (tumor)CDX2, SMARCA4, CFTR, KDM5B, SMARCA2, CREBBP, CDK2, GSK3B, BCL2, SMARCB1, EP300, HNF1A, UBA52, PABPC1, CLDN2, PAX6, ACAT2, MUC4, MEX3B, GUCY2C, UGT1A6 (normal)
bullet pointbullet point
COAD (tumor)COAD (normal)
CDX2, SMARCA4, CFTR, KDM5B, SMARCA2, CREBBP, CDK2, SMARCB1, EP300, SMARCD1, HNF1A, UBA52, PABPC1, PAX6, ACAT2, SI, MUC4, NOX1, MEX3B, GUCY2C, UGT1A6 (tumor)CDX2, SMARCA4, CFTR, KDM5B, MAPK1, CREBBP, GSK3B, MAPK14, BCL2, EP300, HNF1A, UBA52, PABPC1, ACAT2, SI, MUC4, NOX1, MUC2, MEX3B, GUCY2C, UGT1A6 (normal)
bullet pointbullet point
HNSC (tumor)HNSC (normal)
CDX2, SMARCA4, CFTR, MAPK1, SMARCA2, CREBBP, GSK3B, MAPK14, EP300, HNF1A, UBA52, PABPC1, CLDN2, PAX6, ACAT2, SI, MUC4, NOX1, MUC2, MEX3B, GUCY2C (tumor)CDX2, CFTR, KDM5B, MAPK1, SMARCA2, CREBBP, CDK2, GSK3B, MAPK14, BCL2, SMARCB1, EP300, HNF1A, UBA52, PAX6, MUC4, NOX1, MUC2, MEX3B, GUCY2C, UGT1A6 (normal)
bullet pointbullet point
KICH (tumor)KICH (normal)
CDX2, SMARCA4, CFTR, MAPK1, SMARCA2, CREBBP, CDK2, GSK3B, MAPK14, SMARCB1, EP300, HNF1A, UBA52, PABPC1, CLDN2, PAX6, ACAT2, MUC4, MUC2, GUCY2C, UGT1A6 (tumor)CDX2, SMARCA4, KDM5B, MAPK1, SMARCA2, CREBBP, GSK3B, BCL2, SMARCB1, EP300, HNF1A, UBA52, PABPC1, CLDN2, PAX6, ACAT2, MUC4, NOX1, MUC2, GUCY2C, UGT1A6 (normal)
bullet pointbullet point
KIRC (tumor)KIRC (normal)
CDX2, CFTR, MAPK1, SMARCA2, CDK2, GSK3B, BCL2, EP300, SMARCD1, HNF1A, UBA52, PABPC1, CLDN2, PAX6, ACAT2, SI, MUC4, NOX1, MUC2, GUCY2C, UGT1A6 (tumor)CDX2, CFTR, MAPK1, SMARCA2, CREBBP, CDK2, MAPK14, BCL2, EP300, SMARCD1, HNF1A, UBA52, PABPC1, CLDN2, ACAT2, SI, NOX1, MUC2, MEX3B, GUCY2C, UGT1A6 (normal)
bullet pointbullet point
KIRP (tumor)KIRP (normal)
CDX2, CFTR, KDM5B, MAPK1, SMARCA2, CDK2, GSK3B, MAPK14, EP300, HNF1A, UBA52, PABPC1, CLDN2, PAX6, ACAT2, MUC4, NOX1, MUC2, MEX3B, GUCY2C, UGT1A6 (tumor)CDX2, SMARCA4, CFTR, KDM5B, MAPK1, SMARCA2, CDK2, GSK3B, SMARCB1, EP300, SMARCD1, HNF1A, UBA52, PABPC1, PAX6, SI, MUC4, NOX1, MUC2, MEX3B, GUCY2C (normal)
bullet pointbullet point
LIHC (tumor)LIHC (normal)
CDX2, SMARCA4, CFTR, KDM5B, SMARCA2, GSK3B, MAPK14, SMARCB1, EP300, HNF1A, UBA52, CLDN2, PAX6, ACAT2, SI, MUC4, NOX1, MUC2, MEX3B, GUCY2C, UGT1A6 (tumor)CDX2, SMARCA4, CFTR, KDM5B, SMARCA2, CDK2, GSK3B, BCL2, SMARCB1, SMARCD1, UBA52, PABPC1, CLDN2, ACAT2, SI, MUC4, NOX1, MUC2, MEX3B, GUCY2C, UGT1A6 (normal)
bullet pointbullet point
LUAD (tumor)LUAD (normal)
CDX2, SMARCA4, CREBBP, CDK2, GSK3B, MAPK14, BCL2, EP300, SMARCD1, HNF1A, UBA52, CLDN2, PAX6, ACAT2, SI, MUC4, NOX1, MUC2, MEX3B, GUCY2C, UGT1A6 (tumor)CDX2, SMARCA4, CFTR, KDM5B, SMARCA2, CDK2, GSK3B, MAPK14, BCL2, SMARCB1, SMARCD1, HNF1A, UBA52, PABPC1, CLDN2, ACAT2, SI, NOX1, MUC2, GUCY2C, UGT1A6 (normal)
bullet pointbullet point
LUSC (tumor)LUSC (normal)
CDX2, SMARCA4, KDM5B, MAPK1, SMARCA2, CREBBP, CDK2, GSK3B, BCL2, SMARCB1, EP300, HNF1A, UBA52, PABPC1, PAX6, ACAT2, MUC4, NOX1, MUC2, MEX3B, GUCY2C (tumor)CDX2, SMARCA4, MAPK1, SMARCA2, CDK2, GSK3B, MAPK14, BCL2, SMARCB1, EP300, SMARCD1, HNF1A, PABPC1, CLDN2, PAX6, ACAT2, SI, MUC4, MUC2, MEX3B, GUCY2C (normal)
bullet pointbullet point
PRAD (tumor)PRAD (normal)
CDX2, CFTR, KDM5B, SMARCA2, GSK3B, MAPK14, BCL2, SMARCB1, EP300, HNF1A, UBA52, PABPC1, CLDN2, PAX6, ACAT2, SI, MUC4, NOX1, MUC2, MEX3B, GUCY2C (tumor)CDX2, SMARCA4, CFTR, KDM5B, MAPK1, GSK3B, MAPK14, BCL2, EP300, SMARCD1, HNF1A, UBA52, PABPC1, CLDN2, PAX6, SI, MUC4, NOX1, MUC2, GUCY2C, UGT1A6 (normal)
bullet pointbullet point
STAD (tumor)STAD (normal)
CDX2, CFTR, KDM5B, MAPK1, SMARCA2, CREBBP, GSK3B, MAPK14, BCL2, SMARCB1, EP300, SMARCD1, HNF1A, PABPC1, CLDN2, PAX6, SI, MUC2, MEX3B, GUCY2C, UGT1A6 (tumor)CDX2, SMARCA4, CFTR, KDM5B, MAPK1, SMARCA2, CDK2, MAPK14, EP300, SMARCD1, HNF1A, PABPC1, CLDN2, PAX6, ACAT2, SI, MUC4, NOX1, MUC2, MEX3B, GUCY2C (normal)
bullet pointbullet point
THCA (tumor)THCA (normal)
CDX2, SMARCA4, CFTR, KDM5B, MAPK1, SMARCA2, CREBBP, CDK2, GSK3B, MAPK14, BCL2, SMARCB1, EP300, UBA52, PABPC1, CLDN2, ACAT2, MUC4, NOX1, MEX3B, GUCY2C (tumor)CDX2, CFTR, KDM5B, SMARCA2, CDK2, GSK3B, MAPK14, SMARCB1, SMARCD1, UBA52, PABPC1, CLDN2, PAX6, ACAT2, SI, MUC4, NOX1, MUC2, MEX3B, GUCY2C, UGT1A6 (normal)
bullet pointbullet point


Top
TissGeneProg for CDX2

check button Kaplan-Meier plots with logrank tests of overall survival (OS) using 28 cancer types
(TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16)
(TCGA clinicalMatrix, phenotype data, version 2016-04-27)
* Click on the image to enlarge it in a new window.
survival 1

check button Kaplan-Meier plots with logrank test of relapse free survival (RFS) using 28 cancer types
(TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16)
(TCGA clinicalMatrix, phenotype data, version 2016-04-27)
* Click on the image enlarge it in a new window.
survival 2

check button Forest plot of Cox proportional hazard ratio (HR) and 95% CI of overall survival (OS) using 28 cancer types
(TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16)
(TCGA clinicalMatrix, phenotype data, version 2016-04-27)
* Click on the image enlarge it in a new window.
survival 3

check button Forest plot of Cox proportional hazard ratio (HR) and 95% CI of relapse free survival (RFS) using 28 cancer types
(TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16)
(TCGA clinicalMatrix, phenotype data, version 2016-04-27)
* Click on the image enlarge it in a new window.
survival 4

Top
TissGeneClin for CDX2
TissGeneDrug for CDX2

check button Drug information targeting TissGene
(DrugBank Version 5.0.6, 2017-04-01)
DrugBank IDDrug nameDrug activityDrug typeDrug status


Top
TissGeneDisease for CDX2

check button Disease information associated with TissGene
(DisGeNet, 2016-06-01)
Disease IDDisease name# pubmedsSource
umls:C0009402Colorectal Carcinoma45BeFree
umls:C1527249Colorectal Cancer41BeFree,GAD
umls:C0699791Stomach Carcinoma33BeFree
umls:C0699790Colon Carcinoma30BeFree
umls:C0001418Adenocarcinoma28BeFree,LHGDN
umls:C0007102Malignant tumor of colon28BeFree
umls:C0024623Malignant neoplasm of stomach27BeFree
umls:C0596263Carcinogenesis27BeFree
umls:C0023467Leukemia, Myelocytic, Acute10BeFree,LHGDN
umls:C0009404Colorectal Neoplasms9BeFree,LHGDN
umls:C0025568Metaplasia8LHGDN
umls:C0009375Colonic Neoplasms7BeFree,LHGDN
umls:C0038356Stomach Neoplasms6BeFree,LHGDN
umls:C0279628Adenocarcinoma Of Esophagus6BeFree
umls:C0376358Malignant neoplasm of prostate6BeFree
umls:C0600139Prostate carcinoma6BeFree
umls:C0686619Secondary malignant neoplasm of lymph node6BeFree
umls:C0007137Squamous cell carcinoma5BeFree
umls:C0009376Colonic Polyps5BeFree
umls:C0017154Gastritis, Atrophic5BeFree,LHGDN
umls:C0017168Gastroesophageal reflux disease5BeFree
umls:C0023418leukemia5BeFree
umls:C0027627Neoplasm Metastasis5BeFree,LHGDN
umls:C0374997Helicobacter pylori (H. pylori) infection in conditions classified elsewhere and of unspecified site5BeFree
umls:C0004763Barrett Esophagus4BeFree,LHGDN
umls:C0006142Malignant neoplasm of breast4BeFree
umls:C0021846Intestinal Polyps4BeFree
umls:C0178874Tumor Progression4BeFree
umls:C0598766Leukemogenesis4BeFree
umls:C0678222Breast Carcinoma4BeFree
umls:C0850666Helicobacter pylori infection4BeFree
umls:C1319315Adenocarcinoma of large intestine4BeFree
umls:C0001430Adenoma3BeFree
umls:C0007130Mucinous Adenocarcinoma3BeFree
umls:C0007131Non-Small Cell Lung Carcinoma3BeFree
umls:C0018552Hamartoma3BeFree
umls:C0029456Osteoporosis3BeFree
umls:C0029925Ovarian Carcinoma3BeFree
umls:C0032584polyps3BeFree
umls:C0041296Tuberculosis3BeFree
umls:C0085669Acute leukemia3BeFree
umls:C0152013Adenocarcinoma of lung (disorder)3BeFree
umls:C0206754Neuroendocrine Tumors3BeFree
umls:C0235974Pancreatic carcinoma3BeFree
umls:C0267187Intestinal metaplasia of gastric mucosa3BeFree
umls:C1140680Malignant neoplasm of ovary3BeFree
umls:C1709246Non-Neoplastic Disorder3BeFree
umls:C0007114Malignant neoplasm of skin2BeFree
umls:C0014868Esophagitis2BeFree
umls:C0017152Gastritis2BeFree
umls:C0021841Intestinal Neoplasms2BeFree
umls:C0023449Acute lymphocytic leukemia2BeFree
umls:C0023452Leukemia, Lymphocytic, Acute, L12BeFree
umls:C0025202melanoma2BeFree
umls:C0032580Adenomatous Polyposis Coli2BeFree
umls:C0153452Malignant neoplasm of gallbladder2BeFree
umls:C0206677Adenomatous Polyps2BeFree
umls:C0206698Cholangiocarcinoma2BeFree,LHGDN
umls:C0265325Turcot syndrome (disorder)2BeFree
umls:C0278701Gastric Adenocarcinoma2BeFree
umls:C0333983Hyperplastic Polyp2BeFree
umls:C0345893Juvenile polyposis syndrome2BeFree
umls:C0346647Malignant neoplasm of pancreas2BeFree
umls:C0677886Epithelial ovarian cancer2BeFree
umls:C0685938Malignant neoplasm of gastrointestinal tract2BeFree
umls:C0940937precancerous lesions2BeFree
umls:C0948380Colorectal cancer metastatic2BeFree
umls:C1134719Invasive Ductal Breast Carcinoma2BeFree
umls:C1176475Ductal Carcinoma2BeFree,LHGDN
umls:C1335302Pancreatic Ductal Adenocarcinoma2BeFree
umls:C1961102Precursor Cell Lymphoblastic Leukemia Lymphoma2BeFree
umls:C0002793Anaplasia1BeFree
umls:C0005403Bile Reflux1BeFree
umls:C0007113Rectal Carcinoma1BeFree
umls:C0008350Cholelithiasis1LHGDN
umls:C0008626Congenital chromosomal disease1BeFree
umls:C0010346Crohn Disease1LHGDN
umls:C0011860Diabetes Mellitus, Non-Insulin-Dependent1BeFree
umls:C0014170Endometrial Neoplasms1LHGDN
umls:C0014859Esophageal Neoplasms1BeFree,LHGDN
umls:C0014869Peptic Esophagitis1BeFree
umls:C0020505Hyperphagia1BeFree
umls:C0021390Inflammatory Bowel Diseases1BeFree
umls:C0023473Myeloid Leukemia, Chronic1BeFree
umls:C0023903Liver neoplasms1BeFree
umls:C0024117Chronic Obstructive Airway Disease1BeFree
umls:C0024121Lung Neoplasms1BeFree
umls:C0026769Multiple Sclerosis1BeFree
umls:C0030286Pancreatic Diseases1BeFree
umls:C0030297Pancreatic Neoplasm1LHGDN
umls:C0031269Peutz-Jeghers Syndrome1BeFree
umls:C0032927Precancerous Conditions1BeFree
umls:C0034885Rectal Neoplasms1BeFree
umls:C0085695Chronic gastritis1BeFree
umls:C0149521Pancreatitis, Chronic1BeFree
umls:C0149925Small cell carcinoma of lung1BeFree
umls:C0151544Gastrointestinal carcinoma1BeFree
umls:C0152018Esophageal carcinoma1BeFree
umls:C0153676Secondary malignant neoplasm of lung1BeFree
umls:C0205645Adenocarcinoma, Tubular1BeFree
umls:C0206693Medullary carcinoma1LHGDN
umls:C0206699Cystadenocarcinoma, Mucinous1BeFree
umls:C0221273Juvenile polyp1BeFree
umls:C0235782Gallbladder Carcinoma1BeFree
umls:C0242379Malignant neoplasm of lung1BeFree
umls:C0262584Carcinoma, Small Cell1BeFree
umls:C0268837Cystitis glandularis1BeFree
umls:C0278883Metastatic melanoma1BeFree
umls:C0279682Bladder Adenocarcinoma1BeFree
umls:C0281361Adenocarcinoma of pancreas1BeFree
umls:C0311277Obesity, Abdominal1BeFree
umls:C0334092Hamartomatous polyp1BeFree
umls:C0334108Multiple polyps1BeFree
umls:C0338106Adenocarcinoma of colon1BeFree
umls:C0346627Intestinal Cancer1BeFree
umls:C0346976Secondary malignant neoplasm of pancreas1BeFree
umls:C0476089Endometrial Carcinoma1BeFree
umls:C0546837Malignant neoplasm of esophagus1BeFree
umls:C0677659Gastro-esophageal reflux disease with esophagitis1BeFree
umls:C0684249Carcinoma of lung1BeFree
umls:C0741682Premenopausal breast cancer1BeFree
umls:C0741899Poorly differentiated carcinoma1BeFree
umls:C0851887Adenoviral infections1BeFree
umls:C0878500Intraepithelial Neoplasia1BeFree
umls:C1168401Squamous cell carcinoma of the head and neck1BeFree
umls:C1265996Large cell neuroendocrine carcinoma1BeFree
umls:C1292769Precursor B-cell lymphoblastic leukemia1BeFree
umls:C1333990Hereditary Nonpolyposis Colorectal Cancer1BeFree
umls:C1334763Midgut Carcinoid Tumor1BeFree
umls:C1334811Mucinous Neoplasm1BeFree
umls:C1513718Mucin-Producing Intrahepatic Cholangiocarcinoma1BeFree
umls:C1527349Ductal Breast Carcinoma1BeFree
umls:C1527408Rectal Tumors1BeFree
umls:C1559271Non-Malignant Ascites Adverse Event1BeFree
umls:C1739363Prostatic Hypertrophy1BeFree
umls:C1845055ALPHA-THALASSEMIA/MENTAL RETARDATION SYNDROME, NONDELETION TYPE, X-LINKED1BeFree
umls:C1879344Biliary papillomatosis1BeFree
umls:C2239176Liver carcinoma1BeFree
umls:C3272530Intestinal Neuroendocrine Carcinoma1BeFree
umls:C3811653Experimental Organism Basal Cell Carcinoma1BeFree